1.16. Analysis.
Comparison 1 Surgery versus non‐surgery, Outcome 16 Comorbitidies: metabolic syndrome.
| Comorbitidies: metabolic syndrome | ||||
|---|---|---|---|---|
| Study | Outcome | Surgery | No surgery | P value |
| Dixon 2008 | Metabolic syndrome (NOT meeting criteria) at baseline 2 yrs, n (%) |
1 (3%) | 1 (3%) | |
| Dixon 2008 | Metabolic syndrome (NOT meeting criteria) at 2 years, n (%) | 21 (70%) | 4 (13%) | P < 0.001 |
| Dixon 2008 | ||||
| Dixon 2012 | Metabolic syndrome at baseline, n/N | 19/30 | 24/30 | |
| Dixon 2012 | Metabolic syndrome at 2 years, n/N (% of baseline) | 10/19 (53) | 22/24 (92) | |
| Dixon 2012 | Change in metabolic syndrome, baseline to 2 years, n (%) | ‐9 (47) | ‐2 (8) | P = 0.005 |
| O'Brien 2006 | Metabolic syndrome at baseline, n/N (%) | 15/40 (37.5%) | 15/40 (37.5%) | |
| O'Brien 2006 | Metabolic syndrome at 2 years, n/N (%) | 1/39 (2.7%) | 8/33 (24%) | P = 0.006 |
| O'Brien 2006 | ||||
| Schauer 2012 | Resolution of metabolic syndrome at 12 months, n (%): LRYGB | 30 (65.2) | 13 (35.1) | P = 0.01 |
| Schauer 2012 | Resolution of metabolic syndrome at 12 months, n (%): LSG | 27 (58.7) | 13 (35.1) | P = 0.03 |
| Schauer 2012 | ||||